Kaleigh Marie Malloy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 212 Portland Ave, Old Orchard Beach, ME 04064 Phone: 207-939-4065 |
Mackenzie Holland, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 212 Portland Ave, Old Orchard Beach, ME 04064 Phone: 207-985-7861 |
Mrs. Sarah Nestor Welch Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 28 Jameson Hill Rd, Old Orchard Beach, ME 04064 Phone: 207-934-5751 |
Rebecca L Cowie, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 212 Portland Ave, Old Orchard Beach, ME 04064 Phone: 603-244-0116 |
Ms. Susan Tofani, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 44 Union Ave, Old Orchard Beach, ME 04064 Phone: 207-252-3564 |
Jenah H Newman Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 40 E Emerson Cummings Blvd, Old Orchard Beach, ME 04064 Phone: 207-934-2361 |
News Archive
Centene Corporation and Health Net, Inc. announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Centene will acquire all of the shares of Health Net in a cash and stock transaction valued at approximately $6.8 billion, including the assumption of approximately $500 million of debt.
This week the U.S. Food and Drug Administration filed complaints initiating the first-ever No-Tobacco-Sale Order (NTSO) actions for a group of retailers who have repeatedly violated certain restrictions on the sale and distribution of tobacco products, including sales to minors. Under the law, the FDA may pursue an NTSO against retailers that have a total of five or more repeated violations of those restrictions during compliance inspections within 36 months.
The study, published by Cell Press in the January 15th issue of the journal Neuron, provides intriguing insight into how human behavior can be guided by the perceived behavior of other individuals.
Researchers from Genethon, the AFM-Telethon laboratory, Inserm (UMR 1089, Nantes) and the University of London (Royal Holloway) demonstrated the efficacy of an innovative gene therapy in the treatment of Duchenne muscular dystrophy.
The team, led by researchers at Imperial College London, Queen Mary University of London and Ergon Pharmaceuticals, believes the approach could offer new hope in the treatment of inflammatory conditions like arthritis, autoimmune diseases, and sepsis.
› Verified 9 days ago